BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 25358000)

  • 1. Investigation of hFVIII production in mammary glands of transgenic mice.
    Mohammadian T; Rassi H
    Monoclon Antib Immunodiagn Immunother; 2014 Oct; 33(5):325-9. PubMed ID: 25358000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of human coagulation factor VIII expression directed by cytomegalovirus and mammary gland-specific promoters in HC11 cells and transgenic mice.
    Wang Q; Hao S; Ma L; Zhang W; Wan J; Deng X
    Blood Coagul Fibrinolysis; 2015 Oct; 26(7):755-61. PubMed ID: 26192111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustained high-level expression of full-length human factor VIII and restoration of clotting activity in hemophilic mice using a minimal adenovirus vector.
    Balagué C; Zhou J; Dai Y; Alemany R; Josephs SF; Andreason G; Hariharan M; Sethi E; Prokopenko E; Jan HY; Lou YC; Hubert-Leslie D; Ruiz L; Zhang WW
    Blood; 2000 Feb; 95(3):820-8. PubMed ID: 10648392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel factor VIII variants with a modified furin cleavage site improve the efficacy of gene therapy for hemophilia A.
    Nguyen GN; George LA; Siner JI; Davidson RJ; Zander CB; Zheng XL; Arruda VR; Camire RM; Sabatino DE
    J Thromb Haemost; 2017 Jan; 15(1):110-121. PubMed ID: 27749002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term expression of human coagulation factor VIII in a tolerant mouse model using the φC31 integrase system.
    Chavez CL; Keravala A; Chu JN; Farruggio AP; Cuéllar VE; Voorberg J; Calos MP
    Hum Gene Ther; 2012 Apr; 23(4):390-8. PubMed ID: 22077817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic levels of FVIII following a single peripheral vein administration of rAAV vector encoding a novel human factor VIII variant.
    McIntosh J; Lenting PJ; Rosales C; Lee D; Rabbanian S; Raj D; Patel N; Tuddenham EG; Christophe OD; McVey JH; Waddington S; Nienhuis AW; Gray JT; Fagone P; Mingozzi F; Zhou SZ; High KA; Cancio M; Ng CY; Zhou J; Morton CL; Davidoff AM; Nathwani AC
    Blood; 2013 Apr; 121(17):3335-44. PubMed ID: 23426947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of recombinant human factor VIII in milk of several generations of transgenic rabbits.
    Chrenek P; Ryban L; Vetr H; Makarevich AV; Uhrin P; Paleyanda RK; Binder BR
    Transgenic Res; 2007 Jun; 16(3):353-61. PubMed ID: 17265165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of human blood clotting factor VIII in the mammary gland of transgenic sheep.
    Niemann H; Halter R; Carnwath JW; Herrmann D; Lemme E; Paul D
    Transgenic Res; 1999 Jun; 8(3):237-47. PubMed ID: 10478493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of Adeno-Associated Viral Vector-Mediated Human Factor VIII Gene Therapy in Hemophilia A Mice.
    Greig JA; Wang Q; Reicherter AL; Chen SJ; Hanlon AL; Tipper CH; Clark KR; Wadsworth S; Wang L; Wilson JM
    Hum Gene Ther; 2017 May; 28(5):392-402. PubMed ID: 28056565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of active human blood clotting factor VIII in mammary gland of transgenic rabbits.
    Hiripi L; Makovics F; Halter R; Baranyi M; Paul D; Carnwath JW; Bösze Z; Niemann H
    DNA Cell Biol; 2003 Jan; 22(1):41-5. PubMed ID: 12590736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient stabilization of recombinant human coagulation factor VIII in the milk of transgenic mice using hFVIII and vWF co-expression vector transduction.
    Ren X; Gong X; Cai Q; Guo X; Xu M; Ren Z; Zeng Y
    Biotechnol Lett; 2015 Jun; 37(6):1187-94. PubMed ID: 25700825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temporal and spatial expression of biologically active human factor VIII in the milk of transgenic mice driven by mammary-specific bovine alpha-lactalbumin regulation sequences.
    Chen CM; Wang CH; Wu SC; Lin CC; Lin SH; Cheng WT
    Transgenic Res; 2002 Jun; 11(3):257-68. PubMed ID: 12113458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transient blockade of the inducible costimulator pathway generates long-term tolerance to factor VIII after nonviral gene transfer into hemophilia A mice.
    Peng B; Ye P; Blazar BR; Freeman GJ; Rawlings DJ; Ochs HD; Miao CH
    Blood; 2008 Sep; 112(5):1662-72. PubMed ID: 18574023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased transgene integration efficiency upon microinjection of DNA into both pronuclei of rabbit embryos.
    Chrenek P; Vasicek D; Makarevich AV; Jurcik R; Suvegova K; Parkanyi V; Bauer M; Rafay J; Batorova A; Paleyanda RK
    Transgenic Res; 2005 Aug; 14(4):417-28. PubMed ID: 16201408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained expression of Epstein-Barr virus episomal vector mediated factor VIII in vivo following muscle electroporation.
    Mei WH; Qian GX; Zhang XQ; Zhang P; Lu J
    Haemophilia; 2006 May; 12(3):271-9. PubMed ID: 16643213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Non-viral vector mediating human coagulation factor VIII gene expression in mouse 32D cell line].
    Yin J; Wang HL; Wang XF; Qu B; Wu WM; Ding QL; Fu QH; Qi ZW; Wang ZY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Dec; 12(6):721-5. PubMed ID: 15631647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of transgenic mice expressing calcitonin as a beta-lactoglobulin fusion protein in mammary gland.
    Niavarani A; Dehghanizadeh S; Zeinali S; Karimi M; Magliano M; Rassoulzadegan M
    Transgenic Res; 2005 Oct; 14(5):719-27. PubMed ID: 16245163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High expression reduces an antibody response after neonatal gene therapy with B domain-deleted human factor VIII in mice.
    Xu L; Mei M; Ma X; Ponder KP
    J Thromb Haemost; 2007 Sep; 5(9):1805-12. PubMed ID: 17596134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of tolerance to human factor VIII in mice.
    Chao H; Walsh CE
    Blood; 2001 May; 97(10):3311-2. PubMed ID: 11342466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone marrow stromal cell-mediated gene therapy for hemophilia A: in vitro expression of human factor VIII with high biological activity requires the inclusion of the proteolytic site at amino acid 1648.
    Chiang GG; Rubin HL; Cherington V; Wang T; Sobolewski J; McGrath CA; Gaffney A; Emami S; Sarver N; Levine PH; Greenberger JS; Hurwitz DR
    Hum Gene Ther; 1999 Jan; 10(1):61-76. PubMed ID: 10022531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.